Live tape
Top 8, mentions 7d15,561MSFT3,075 mentions▲ +0.09GOOGL2,146 mentions▲ +0.05AAPL2,107 mentions▲ +0.07META2,077 mentions▲ +0.04SNDK1,812 mentions▲ +0.06NVDA1,591 mentions▲ +0.07SPCX1,535 mentions▲ +0.06QQQ1,218 mentions▲ +0.04

Equity · Healthcare

RCUS

Arcus Biosciences, Inc. · NYSE

$27.38 +1.41% 1D Finazon · prior-day close · Jul 17, 2026
Price · Chart Chart by TradingView

The chart above plots the price of RCUS over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 55 sessions over that window: $26.07 on 4 May 2026 through $27.38 on 17 July 2026. Finazon · prior-day close.

Market cap $3.4B
52-week range $9.00 – $31.01
Avg volume 267.6K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Jul 29, 2026

RCUS insider trades

SEC Form 4 · last 90 days · newest reported trade 10 Jul 2026
Open-market buys 0
Open-market sells 7
Net sold $3.17M
Non-trade filings 8
Date Insider Type Shares Value
10 Jul 2026 Jaen Juan C. President Sell 20,067 $574K
09 Jul 2026 Jaen Juan C. President Sell 48,502 $1.46M
24 Jun 2026 Jaen Juan C. President Sell 6,431 $191K
23 Jun 2026 Jaen Juan C. President Sell 15,764 $437K
22 Jun 2026 Jaen Juan C. President Sell 9,236 $250K

Showing the 12 most recent of 15 filings in this window. The figures above count all of them.

Compensation mechanics (7 filings)

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
11 Jun 2026 PERLMAN ANDREW J Director Award 5,700
11 Jun 2026 FALBERG KATHRYN E Director Award 5,700
11 Jun 2026 KANEKO YASUNORI Director Award 5,700
11 Jun 2026 Machado Patrick Director Award 5,700
11 Jun 2026 Lacey David L. Director Award 5,700
11 Jun 2026 Lambert Nicole Director Award 5,700
11 Jun 2026 Ribas Antoni Director Award 5,700

RCUS reported financials

SEC EDGAR XBRL

RCUS reported revenue of $33.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$353.0M.

Figure Reported Period
Revenue $33.0M 31 Dec 2025 fiscal year
Net income −$353.0M 31 Dec 2025 fiscal year
Diluted EPS −$3.29 31 Dec 2025 fiscal year
Total assets $997.0M 31 Mar 2026 at period end
Total equity $524.0M 31 Mar 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 31 Mar 2026

RCUS earnings

SEC EDGAR
Date Period EPS Revenue
31 Mar 2026 Q1 2026 $-1.02 $17M
31 Dec 2025 FY 2025 $-3.29 $247M
30 Sep 2025 Q3 2025 $-1.27 $26M
30 Jun 2025 Q2 2025 $0.00 $160M

Reported figures & scheduled dates · SEC EDGAR filings

RCUS institutional holders

SEC Form 13F

11 of the 45 institutional funds we track reported a RCUS position for the quarter ended 31 Mar 2026 — a combined $198.9M; the latest of those filings landed 15 May 2026.

Fund Action Shares Value
Marshall Wace Held (±25%) +11.0% shares 3,761,437 $81.2M
Fisher Asset Management Held (±25%) +12.3% shares 2,190,404 $47.3M
Citadel Advisors Added +1,170.2% shares 1,329,935 $28.7M
Renaissance Technologies Added +1,198.8% shares 424,700 $9.2M
Baker Bros. Advisors Added +53.9% shares 415,621 $9.0M
Two Sigma Investments Added +123.9% shares 312,690 $6.8M
D. E. Shaw & Co. Added +203.1% shares 259,400 $5.6M
Tudor Investment Corp Held (±25%) +3.7% shares 216,311 $4.7M
Point72 Asset Management Trimmed −96.1% shares 129,273 $2.8M
AQR Capital Management Held (±25%) +0.1% shares 86,294 $1.9M

Source: SEC EDGAR 13F filings

RCUS fails-to-deliver

SEC CNS data

On 29 Jun 2026, 19,066 shares of RCUS failed to deliver (about $591K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
29 Jun 2026 19,066 $591K 0.015%
26 Jun 2026 19,786 $599K 0.016%
24 Jun 2026 99,943 $2.8M 0.079%
23 Jun 2026 99,943 $2.7M 0.079%
22 Jun 2026 672 $16K 0.001%
18 Jun 2026 68 $2K <0.001%
17 Jun 2026 2,560 $60K 0.002%
16 Jun 2026 3,607 $87K 0.003%

Source: SEC fails-to-deliver (CNS) data